Data on PMD is limited to affected pregnancies because of the disorder's relatively recent recognition[13]. The aim of this paper was to emphasize the recognition and diagnosis of this new entity.
We describe the clinical, gross and histopathological findings of PMD in two cases in this report.
Figure 1: Placenta with prominent thick vessels (white arrow) and white nodule (black arrow).
Case 2: A 40-year-old gravida 2, para 1 woman in her 18th week of gestation, was referred to Akdeniz University Gynecology and Obstetrics Department, with a nuchal translucency measurement of 2.29 mm and combined risk of > 1/5 for Down's syndrome detected in the first trimester screening test for fetal aneuploidy. Her personal and family histories were unremarkable. Her previous pregnancy was uneventful and the child was healthy. Her non-consanguineous husband was 45 years old.
An amniocentesis was performed the same day to analyze the fetal karyotype. Trisomy 21 was revealed two weeks later. The parents chose pregnancy termination after receiving counseling about Down's syndrome. The karyotype was trisomy 21 and macroscopically the 288 gram placenta had thick-walled vessels on the placental disc.
Microscopically variable villous maturation was present, ranging from mature with increased syncytial knotting to enlarged stem villi in both cases. The abnormal stem villi were large and edematous and contained peripherally localized, prominent thick-walled vessels of which some were obstructed (Figure 2,3). Trophoblastic cell proliferation and stromal inclusions were not observed. Evidence of villous edema was seen in some of the villi cisternae. These cisternae were negative for CD34 and D2- 40 on immunohistochemical staining (Figure 4, 5). These findings were consistent with PMD.
Figure 2: Light microscopy of Case 1 (H&E; x10).
Figure 3: Light microscopy of Case 1 (H&E; x20).
Figure 4: Villus with CD34 negative cisternae (CD34; x5).
Figure 5: Villus with D2-40 negative cisternae (D2-40; x10).
PMD is a rare benign placental anomaly that is difficult to differentiate from a complete mole with co-twin. Differential diagnosis of PMD and molar pregnancy is important because complete mole and partial mole carry significant morbidity for mother[16]. On the other hand, PMD is benign disorder and termination is not needed so that only clinical follow-up is offered. PMD should be included in the differential diagnosis of sonographic findings that show a normal appearing fetus with cystic lesions of placenta[11]. Detection of PMD is not only necessary for differential diagnosis of hydatidiform mole but also for clinical follow-up because it is said that PMD has a relationship with pregnancy-related hypertension[16]. However, it is not known whether PMD is the result or the reason of pregnancy- related hypertension. In contrast to the literature, neither of our cases had pregnancy-related hypertension, pre-eclampsia or eclampsia. One of our cases had a cardiovascular disorder history that was associated with atrial-mitral valve impairment and resulted in valve replacement. This case had a history of hypertension but her blood pressure was under control before and during the pregnancy. Also our second case had no history of hypertension or pregnancy-related hypertension.
Neither case was diagnosed prenatally because the placental changes were not prominent enough for prenatal diagnosis but macroscopically both had an enlarged placenta with thick-walled vessels suggesting PMD. One of our cases had a chromosomal abnormality, trisomy 21, in which hydropic villi and mild degrees of circumferential trophoblastic proliferation could be observed and this would be challenging when making the differential diagnosis of PHM[17,18]. To the best of our knowledge, our case is the first PMD case associated with trisomy 21. It is known that hydropic villi can be seen in trisomy 21[17,18] but peripherally located thick-walled vessels and the absence of trophoblastic proliferation were the most important clues for the diagnosis of PMD[15,16]. In both of our cases, some of the villi were hydropic and had cisternae, while some had peripherally located thick-walled vessels. These findings confirmed the diagnosis of PMD.
PMD cases have been associated with the Beckwith- Wiedemann Syndrome (BWS) in many cases in the literature[14,19,20]. The classic form of BWS includes hyperplastic visseromegaly, macroglossia, omphalocele, adrenal cytomegaly and gigantism. The association of PMD and BWS was first recognized by Lage in her series of four cases of BWS associated with placentomegaly with massive hydrops of placental stem villi and diploid DNA content[21]. In PMD cases, the fetuses are usually normal but have BWS features in 25-30%[14,19,20]. We did not observe any features of Beckwith-Wiedemann Syndrome in our cases.
Diagnosis of PMD is both prenatally and also histopathologically difficult. Early cases of PMD have been confused with partial hydatidiform mole (PHM)[6-10,22]. Molar pregnancies are characterized by massive fluid accumulation within the villous parenchyma that leads to formation of microcysts within the villi and trophoblastic proliferation. Fetal blood vessels are usually absent[23]. PMD is an increasingly recognized abnormality that presents with placentomegaly, marked stem vessel hydrops, mesenchymal dysplasia with prominent thickwalled vessels, enlarged villi with myxoid stroma and decreased, occasionally obliterated blood vessels. Some of the surface vessels are thrombotic but the trophoblasts seem to be normal[3,23,24]. The most important clue for the differential diagnosis of PHM from PMD is absence of abnormal trophoblastic proliferations and trophoblastic pseudoinclusions[3]. Placentomegaly, mesenchymal dysplasia with prominent thick-walled vessels, enlarged hydropic villi with cisternae were observed, but trophoblastic proliferations and trophoblastic pseudoinclusions were absent in our two cases.
In conclusion, PMD is an increasingly recognized placental pathology that should be differentiated from partial mole hydatidiform. Unlike molar pregnancies, PMD co-exists with viable fetuses. There is also an association with PMD and BWS. The most important message is that PMD should be considered in the differential diagnosis of a case with a normal-appearing fetus and placenta with cystic lesions. The most important point is you can diagnose it if you consider it.
1) Takayama M, Soma H, Yaguchi S, Funayama H, Fujiwara K, Irie H,
Yamabe S. Abnormally large placenta associated with Beckwith-
Wiedemann syndrome. Gynecol Obstet Invest. 1986;22:165-8.
2) Moscoso G, Jauniaux E, Hustin J. Placental vascular anomaly with
diffuse mesenchymal stem villous hyperplasia. A new clinicopathological
entity? Pathol Res Pract. 1991;187:324-8.
3) Surti U, Hill LM, Dunn J, Prosen T, Hoffner L. Twin pregnancy
with a chimeric androgenetic and biparental placenta in one twin
displaying placental mesenchymal dysplasia phenotype. Prenat
Diagn. 2005;25:1048-56.
4) Zeng X, Chen MF, Bureau YA, Brown R. Placental mesenchymal
dysplasia and an estimation of the population incidence. Acta
Obstet Gynecol Scand. 2012;91:754-7.
5) R obertson M, Geerts LT, de Jong G, Wainwright H. Mesenchymal
dysplasia in a monochorionic diamniotic twin pregnancy with
review of the differential diagnosis of cystic changes in the
placenta. J Ultrasound Med. 2007;26:689-93.
6) Matsui H, Iitsuka Y, Yamazawa K, Tanaka N, Mitsuhashi A, Seki
K, Sekiya S. Placental mesenchymal dysplasia initially diagnosed
as partial mole. Pathol Int. 2003;53:810-3.
7) Sander CM. Angiomatous malformation of placental chorionic
stem vessels and pseudo-partial molar placentas: Report of five
cases. Pediatr Pathol. 1993;13:621-33.
8) Hojberg KE, Aagaard J, Henriques U, Sunde L. Placental vascular
malformation with mesenchymal hyperplasia and a localized
chorioangioma. A rarity simulating partial mole. Pathol Res
Pract. 1994;190:808-13; discussion 14.
9) Pridmore BR, Khong TY, Wells WA. Ultrasound placental cysts
associated with massive placental stem villous hydrops, diploid
DNA content, and exomphalos. Am J Perinatol. 1994;11:14-8.
10) Zhang P, Benirschke K. Placental pathology casebook. Serpentine
aneurysms of the placenta with fetal consequences. J Perinatol.
2000;20:63-5.
11) Parveen Z, Tongson-Ignacio JE, Fraser CR, Killeen JL, Thompson
KS. Placental mesenchymal dysplasia. Arch Pathol Lab Med.
2007;131:131-7.
12) Gizzo S, Di Gangi S, Patrelli TS, Saccardi C, D'Antona D, Nardelli
GB. Placental mesenchymal dysplasia: Can early diagnosis ensure
a good materno-foetal outcome? A case report. Arch Gynecol
Obstet. 2012;286:15-7.
13) N ayeri UA, West AB, Grossetta Nardini HK, Copel JA, Sfakianaki
AK. Systematic review of sonographic findings of placental
mesenchymal dysplasia and subsequent pregnancy outcome.
Ultrasound Obstet Gynecol. 2013;41:366-74.
14) Heazell AE, Sahasrabudhe N, Grossmith AK, Martindale EA,
Bhatia K. A case of intrauterine growth restriction in association
with placental mesenchymal dysplasia with abnormal placental
lymphatic development. Placenta. 2009;30:654-7.
15) Gibson BR, Muir-Padilla J, Champeaux A, Suarez ES.
Mesenchymal dysplasia of the placenta. Placenta. 2004;25:671-2.
16) Woo GW, Rocha FG, Gaspar-Oishi M, Bartholomew ML,
Thompson KS. Placental mesenchymal dysplasia. Am J Obstet
Gynecol. 2011;205:e3-5.
17) R eichert RA. Diagnostic Gynecologic and Obstetric Pathology:
An Atlas and Text. Philadelphia: Lippincott Williams & Wilkins;
2012.
18) Chew SH, Perlman EJ, Williams R, Kurman RJ, Ronnett BM.
Morphology and DNA content analysis in the evaluation of first
trimester placentas for partial hydatidiform mole (PHM). Human
pathology. 2000;31:914-24.
19) Kaiser-Rogers KA, McFadden DE, Livasy CA, Dansereau J, Jiang
R, Knops JF, Lefebvre L, Rao KW, Robinson WP. Androgenetic/
biparental mosaicism causes placental mesenchymal dysplasia. J
Med Genet. 2006;43:187-92.
20) Cohen MC, Roper EC, Sebire NJ, Stanek J, Anumba DO. Placental
mesenchymal dysplasia associated with fetal aneuploidy. Prenat
Diagn. 2005;25:187-92.
21) L age JM. Placentomegaly with massive hydrops of placental
stem villi, diploid DNA content, and fetal omphaloceles: Possible
association with Beckwith-Wiedemann syndrome. Hum Pathol.
1991;22(6):591-7.
22) Chan YF, Sampson A. Placental mesenchymal dysplasia: A report
of four cases with differentiation from partial hydatidiform mole.
Aust N Z J Obstet Gynaecol. 2003;43:475-9.